Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes

Autor: Efficace, F.1 f.efficace@gimema.it, Cocks, K.2, Breccia, M.3, Sprangers, M.4, Meyers, C.A.5, Vignetti, M.3, Baccarani, M.6, Mandelli, F.1
Zdroj: Critical Reviews in Oncology/Hematology. Feb2012, Vol. 81 Issue 2, p123-135. 13p.
Databáze: Academic Search Ultimate
Externí odkaz: